Position in IVVD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$32,455
+$16,341 QoQ
Shares Held
37,220
+200.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 124 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IVVD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $337,381,357 across 175 Biotechnology names. IVVD ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in IVVD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,455 | 37,220 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $16,114 | 12,396 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $30,232 | 12,240 | Shares | Sole | 2026-02-06 | |
| 2025-03-31 | $10,386 | 17,168 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $9,894 | 22,336 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,283 | 14,984 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $16,316 | 13,597 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $23,428 | 15,619 | Shares | Sole | 2023-02-02 | |
| 2022-03-31 | $50,328 | 11,037 | Shares | Sole | 2022-05-10 | |
| No filing history on record for this holder in this stock. | ||||||